KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis

Govindaraj Anumanthan1,2, Suneel Gupta1,2, Michael K Fink1,2

  • 1Harry S. Truman Memorial Veteran Hospital, Columbia, Missouri, United States of America.

Plos One
|March 20, 2018
PubMed

Insights

Blocking the KCa3.1 channel with TRAM-34 reduces corneal fibrosis. This channel is crucial for corneal wound healing and fibrosis development, offering a new therapeutic target for vision impairment.

Area of Science:

  • Ophthalmology and Vision Science
  • Cell Biology
  • Pharmacology

Background:

  • Corneal fibrosis, a leading cause of vision impairment, results from abnormal wound healing.
  • Intermediate-conductance calmodulin/calcium-activated K+ channels 3.1 (KCa3.1) are implicated in fibrosis in non-ocular tissues but their role in corneal fibrosis is unknown.
  • Understanding KCa3.1's role is crucial for developing novel anti-fibrotic therapies for the cornea.

Purpose of the Study:

  • To characterize KCa3.1 expression in the human cornea.
  • To investigate the role of KCa3.1 in corneal wound healing in vivo using KCa3.1 knockout mice.
  • To evaluate the therapeutic potential of KCa3.1 inhibition with TRAM-34 in an in vitro model of corneal fibrosis.

Main Methods:

  • KCa3.1 gene and protein expression analysis in human and murine corneas.
  • In vitro studies using human corneal fibroblasts (HCFs) treated with TRAM-34, assessing pro-fibrotic markers (qPCR, Western blotting) and cell migration (scratch assay).
  • In vivo assessment of corneal fibrosis in KCa3.1 knockout mice and cytotoxicity testing of TRAM-34.

Main Results:

  • KCa3.1 expression was detected in all layers of the human cornea.
  • KCa3.1 knockout mice exhibited significantly reduced corneal fibrosis and lower expression of pro-fibrotic markers (collagen I, α-SMA).
  • TRAM-34 treatment significantly inhibited TGFβ-mediated pro-fibrotic gene and protein expression in HCFs without observed cytotoxicity.

Conclusions:

  • KCa3.1 plays a significant role in regulating corneal wound healing and fibrosis.
  • Blockade of KCa3.1 by TRAM-34 effectively attenuates corneal fibrosis in vitro.
  • KCa3.1 inhibition represents a promising therapeutic strategy for treating corneal fibrosis and preventing vision impairment.

Related Concept Videos

Ion Channels01:19

Ion Channels

The movement of ions like sodium, potassium, and calcium into and out of the cell is essential to maintain the electrochemical gradient in living cells. The ion channels—a class of membrane transport proteins—help maintain this ionic gradient for the smooth functioning of physiological activities such as maintaining cell size and volume, conducting nerve impulses, and gas and nutrient exchange.
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...
91.5K
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
8.3K
Mechanically-gated Ion Channels01:12

Mechanically-gated Ion Channels

Mechanically-gated ion channels are proteins found in eukaryotic and prokaryotic cell membranes that open in response to mechanical stress. Tension, compression, swelling, and shear stress can alter the conformation of the protein, opening a transmembrane channel that allows the passage of ions for signal transmission. In eukaryotes, mechanically-gated channels are distributed in several regions like the neurons, lungs, skin, bladder, and heart, where they play critical roles in numerous...
7.8K
Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
14.4K
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
11.0K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
5.8K